| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.15B | 28.68B | 27.60B | 25.80B | 22.57B | 14.46B |
| Gross Profit | 14.34B | 14.16B | 13.35B | 12.48B | 11.97B | 7.09B |
| EBITDA | 6.22B | 6.12B | 6.31B | 6.97B | 6.53B | 3.31B |
| Net Income | 2.80B | 3.01B | 3.19B | 4.06B | 4.01B | 1.70B |
Balance Sheet | ||||||
| Total Assets | 36.78B | 35.71B | 34.21B | 33.65B | 30.27B | 14.59B |
| Cash, Cash Equivalents and Short-Term Investments | 17.05B | 15.76B | 8.94B | 8.03B | 15.15B | 7.19B |
| Total Debt | 1.78B | 1.94B | 2.54B | 2.14B | 1.32B | 1.05B |
| Total Liabilities | 9.61B | 9.60B | 9.80B | 9.31B | 9.17B | 5.90B |
| Stockholders Equity | 27.17B | 26.10B | 24.41B | 24.33B | 21.10B | 8.69B |
Cash Flow | ||||||
| Free Cash Flow | 3.52B | 3.76B | 2.87B | 2.08B | 5.50B | 2.02B |
| Operating Cash Flow | 4.95B | 5.27B | 4.69B | 3.91B | 6.53B | 2.76B |
| Investing Cash Flow | 3.14B | -839.62M | -2.45B | -9.48B | -6.54B | -991.55M |
| Financing Cash Flow | -2.33B | -2.32B | -4.22B | -1.89B | 7.60B | -513.49M |
Li Ning Company Limited has deployed a total of RMB1.9 billion of surplus cash into low-risk structured deposit products through several wholly owned subsidiaries between 18 and 26 January 2026. The funds were placed with major Chinese banks, including China Guangfa Bank, Bank of China and China Merchants Bank, in multiple tranches ranging from RMB200 million to RMB700 million, with product tenors of about five to six months and expected annual returns between 0.60% and 3.00%. As these wealth management subscriptions occurred within a 12‑month period, they are aggregated under Hong Kong listing rules and classified as a discloseable transaction, triggering reporting and announcement requirements; the move underscores the company’s effort to enhance returns on idle cash while maintaining a conservative risk profile, with implications for shareholders in terms of liquidity management and interest income.
The most recent analyst rating on (HK:2331) stock is a Buy with a HK$23.50 price target. To see the full list of analyst forecasts on Li Ning Company stock, see the HK:2331 Stock Forecast page.
Li Ning Company Limited reported a modest softening in its core retail performance for the fourth quarter of 2025, with overall retail sell-through at LI-NING branded points of sale (excluding LI-NING YOUNG) declining by a low single digit year-on-year. Offline channels saw a mid-single-digit drop, as direct retail slipped by a low single digit and wholesale franchised outlets by a mid single digit, while e-commerce sales were flat, reflecting a challenging consumption environment and a mixed channel performance. The group continued to fine-tune its physical footprint, ending 2025 with 6,091 LI-NING points of sale in China, a slight net reduction driven by closures in direct retail that were partially offset by growth in wholesale outlets, while its LI-NING YOUNG network expanded to 1,518 stores, underscoring the brand’s focus on the youth segment. The company emphasized that the figures are based on unaudited operational data and may not fully reflect its overall revenue or financial performance, signaling to investors the need for caution ahead of formal financial disclosures.
The most recent analyst rating on (HK:2331) stock is a Buy with a HK$23.20 price target. To see the full list of analyst forecasts on Li Ning Company stock, see the HK:2331 Stock Forecast page.
Li Ning Company has set new annual caps for 2026 under its Restricted Share (RS) Scheme, which is used to purchase company shares from the open market to satisfy the vesting of restricted shares granted to employees and other selected participants. For the period from 1 January to 31 December 2026, the board has approved a Number Annual Cap of 15 million shares and a Referable Amount Annual Cap of HK$300 million, with the effective limit being whichever is lower in value. Because the RS Scheme trustee is deemed an associate of the company’s connected persons, these purchases constitute continuing connected transactions under Hong Kong listing rules, triggering reporting, announcement and annual review obligations but remaining exempt from independent shareholder approval as all relevant percentage ratios are below 5%. The caps were set with reference to past grants, scheme limits, share price performance and anticipated future grants, and the company maintains governance safeguards requiring independent non-executive director approval for any restricted share grants to directors or administration committee members.
The most recent analyst rating on (HK:2331) stock is a Buy with a HK$19.50 price target. To see the full list of analyst forecasts on Li Ning Company stock, see the HK:2331 Stock Forecast page.